Victory Capital Management
AMPE

Victory Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Victory Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-79
Closed -$1K – 2784
2022
Q3 		$1K Sell
79
-15
-16% -$525 ﹤0.01% 2696
2022
Q2 		$5K Sell
94
-1
-1% -$74 ﹤0.01% 2681
2022
Q1 		$7K Sell
95
-3
-3% -$438 ﹤0.01% 2695
2021
Q4 		$17K Buy
98
+9
+10% +$3.36K ﹤0.01% 2700
2021
Q3 		$44K Sell
89
-8
-8% -$3.71K ﹤0.01% 2694
2021
Q2 		$48K Sell
97
-3
-3% -$1.61K ﹤0.01% 2667
2021
Q1 		$50K Buy
100
+3
+3% +$1.55K ﹤0.01% 2667
2020
Q4 		$46K Buy
97
+10
+11% +$3.28K ﹤0.01% 2464
2020
Q3 		$25K Buy
87
+1
+1% +$248 ﹤0.01% 2426
2020
Q2 		$16K Sell
86
-85
-50% -$14.1K ﹤0.01% 2453
2020
Q1 		$22K Buy
+171
New +$31K ﹤0.01% 3075
2019
Q4 		– Sell
-76
Closed -$11K – 3532
2019
Q3 		$11K Buy
+76
New +$10.1K ﹤0.01% 3243

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Victory Capital Management's AMPE Position: Q4 2022 in Review

Victory Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 79 shares — an estimated $1K sold.

Victory Capital Management first reported a position in AMPE in Q3 2019 and held it in 12 quarters. The position peaked at $50K in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Victory Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 79 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $1K.
  • Victory Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q3 2019 and held it in 12 quarters.
  • Victory Capital Management's Ampio Pharmaceuticals Inc. position peaked at $50K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.